Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease

Karar T. Shukur, Tugba Ercetin, Chiara Luise, Wolfgang Sippl, Okan Sirkecioglu, Mert Ulgen, Goknil P. Coskun, Mine Yarim, Mustafa Gazi, Hayrettin O. Gulcan*

*Bu çalışma için yazışmadan sorumlu yazar

Araştırma sonucu: ???type-name???Makalebilirkişi

11 Atıf (Scopus)

Özet

A series of urolithin amide (i.e., URO-4–URO-10 and THU-4–THU-10) derivatives was designed and synthesized, and their chemical structures were confirmed with spectroscopic techniques and elemental analysis. The title compounds and synthesis intermediates (THU-1–THU-10 and URO-1–URO-10) were evaluated for their potential to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidase B (MAO-B). Compounds THU-4 and THU-8 were found to be the most potent inhibitors for the cholinesterases and MAO-B, respectively. The docking studies were also employed to evaluate the binding modes of the most active compounds with AChE, BuChE, and MAO-B. Furthermore, the moderate-to-strong activities of the compounds were also displayed in amyloid-beta inhibition and antioxidant assay systems. The results pointed out that the urolithin scaffold can be employed in drug design studies for the development of multitarget ligands acting on various cascades shown to be important within the pathophysiology of Alzheimer's disease.

Orijinal dilİngilizce
Makale numarası2000467
DergiArchiv der Pharmazie
Hacim354
Basın numarası5
DOI'lar
Yayın durumuYayınlandı - May 2021

Bibliyografik not

Publisher Copyright:
© 2021 Deutsche Pharmazeutische Gesellschaft

Parmak izi

Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

Alıntı Yap